Vanguard Capital Management
AURA icon

Vanguard Capital Management’s Aura Biosciences AURA Stock Holding History

Vanguard Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.1M Buy
4,100,342
+1,856,514
+83% +$13.3M ﹤0.01% 2239
2026
Q1 		$15M Buy
+2,243,828
New +$12.9M ﹤0.01% 2502

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

Vanguard Capital Management's AURA Position: Q2 2026 in Review

Vanguard Capital Management increased its Aura Biosciences (AURA) stake by 83% in Q2 2026, buying an estimated $13.3M and bringing the position to 4,100,342 shares worth $29.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2239.

Vanguard Capital Management first reported a position in AURA in Q1 2026 and has held it in 2 quarters since. 145 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Vanguard Capital Management held 4,100,342 shares of Aura Biosciences worth $29.1M as of Q2 2026.
  • Vanguard Capital Management bought 1,856,514 Aura Biosciences shares in Q2 2026, an estimated $13.3M.
  • Aura Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2239 holding.
  • Vanguard Capital Management first reported a position in Aura Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 145 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.